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The prevalence and importance of microRNAs (miRNAs) in viral infection are increasingly relevant. Eleven
miRNAs were previously identified in human cytomegalovirus (HCMV); however, miRNA content in murine
CMV (MCMV), which serves as an important in vivo model for CMV infection, has not previously been
examined. We have cloned and characterized 17 novel miRNAs that originate from at least 12 precursor
miRNAs in MCMV and are not homologous to HCMV miRNAs. In parallel, we applied a computational
analysis, using a support vector machine approach, to identify potential precursor miRNAs in MCMV. Four
of the top 10 predicted precursor sequences were cloned in this study, and the combination of computational
and cloning analysis demonstrates that MCMV has the capacity to encode miRNAs clustered throughout the
genome. On the basis of drug sensitivity experiments for resolving the kinetic class of expression, we show that
the MCMV miRNAs are both early and late gene products. Notably, the MCMV miRNAs occur on comple-
mentary strands of the genome in specific regions, a feature which has not previously been observed for viral
miRNAs. One cluster of miRNAs occurs in close proximity to the 5 splice site of the previously identified 7.2-kb
stable intron, implying a variety of potential regulatory mechanisms for MCMV miRNAs.
Small noncoding RNAs (ncRNAs) play diverse roles in bi-
ological pathways and are increasingly prevalent in the viral
context (37, 48). One particular class of ncRNAs, microRNAs
(miRNAs), regulates eukaryotic gene expression by binding to
specific mRNA transcripts and initiating their degradation or
repressing their translation (22, 24, 26). Despite the relatively
recent discovery of miRNAs in Caenorhabditis elegans, re-
search in this field has progressed rapidly in a number of
species, and it is now estimated that miRNAs comprise 1% of
genes in animals and may target up to 30% of genes in humans
(28). This highly significant class of molecules, therefore, has
an enormous capacity to modulate the transcriptome, and it is
not surprising that viruses have found a way to exploit this
regulatory system. Given their small size (22 nucleotides [nt])
and their large potential for gene regulation (multiple targets),
miRNAs offer a particularly efficient mechanism for viruses to
manipulate viral and cellular pathways. First discovered in
Epstein-Barr virus (EBV) in 2004 (38), viral miRNAs have
now been characterized in the three herpesvirus subfamilies
(36) and in polyomaviruses (49) and adenoviruses (30, 43).
Reports have also emerged detailing miRNA discovery in ret-
roviruses (3, 35).
In the realm of virus-host interactions, miRNAs have been
shown to function in a variety of capacities (33, 44, 45). Viral
miRNAs can target viral genes, most obviously when the target
is encoded on the opposite strand from the miRNA, as impli-
cated in EBV (10, 38) and demonstrated in simian virus 40
(SV40). In SV40, this can serve in immune evasion, since SV40
miR-S1 targets the viral large T antigen at late stages of infec-
tion and protects cells from being killed by cytotoxic T lym-
phocytes (49). There are also examples of host miRNAs serv-
ing proviral or antiviral functions. Specifically, human mir-32
has an antiviral effect on primate foamy virus 1, since it targets
viral mRNA in kidney cells and inhibits primate foamy virus
replication (25). In contrast, mir-122, a liver-specific host
miRNA, has a proviral effect in hepatitis C virus by interacting
with the 5 noncoding region of the viral genome and increas-
ing its expression (18). Recent reports with herpes simplex
virus type 1 (HSV-1) and human cytomegalovirus (HCMV)
have demonstrated that virus-encoded miRNAs can also target
specific cellular genes involved in apoptosis and host immune
defense. In HSV-1, the virus-encoded mir-LAT down regulates
two proteins (TFGB and SMAD3) which induce apoptosis in
infected cells (16) and thereby contributes to the ability of the
virus to persist in a latent form. In the case of HCMV, mir-
UL112 targets the major histocompatibility complex class I-re-
lated chain B gene, whose absence protects HCMV-infected
cells from lysis by natural killer cells (47).
The majority of published viral miRNAs have been found in
the herpesvirus family (36). There are several reasons which
may explain this. First, double-stranded DNA viruses that rep-
licate in the nucleus are the most likely candidates to utilize the
host miRNA machinery as well as RNA polymerase II, from
which most miRNAs derive (27). Second, since the prototypic
effect of a miRNA is the reduction of target protein produc-
tion, it has been hypothesized that viruses with longer life
cycles or those capable of latent infection (a characteristic of
herpesviruses) are more likely to utilize this regulatory mech-
anism (6). This hypothesis relates to the assumption that a pool
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of target protein must decay before any virus-specific effect can
be observed. It is highly relevant, therefore, to study the func-
tion and mechanisms of miRNA action in herpesvirus systems
which have well-established models for infection and patho-
genesis.
Of particular interest in this regard is HCMV, a member
of the betaherpesvirus family which infects 50 to 90% of the
world’s population and is the most common infectious agent
transmitted via blood transfusion (14). Previous work has
shown that HCMV encodes at least 11 miRNAs (7, 13, 36),
and one of these miRNAs has been shown to target a host
immune system gene (cited above). CMV is highly species
specific; however, the pathogenesis of mouse CMV
(MCMV) in mice is remarkably similar to that of HCMV in
humans. This has resulted in the widespread adoption of the
MCMV model in the study of all aspects of infection and
pathogenesis (19).
In the present study, we examine the presence of miRNAs in
MCMV using both computational and RNA cloning ap-
proaches. This is the first report of miRNAs in MCMV and
should stimulate further work regarding the function of these
molecules in infection.
MATERIALS AND METHODS
MicroRNA prediction analysis. Precursor feature classification using support
vector machines (SVM) was employed to predict the locations of MCMV
miRNA precursor stem-loop structures. Our procedure implemented the follow-
ing steps. (i) Both strands of the MCMV genome (230,278 bp) were scanned
using a sliding window of 104 nt, and RNA secondary structure was predicted
using the RNAfold program (17). (ii) For stable structures with a minimum free
energy of less than 15 kcal/mol, a total of seven structural and energetic
features were extracted and classified using a SVM trained on known positive
and negative miRNA examples. Using a probability model (40), the SVM gen-
erates a score for each hairpin ranging from 0 to 1.3. As there is evidence that
miRNA precursors, unlike other ncRNAs, have lower folding free energies than
random sequences, this property was assessed using the RANDfold program (4).
Cells and viruses. Primary mouse embryonic fibroblasts (MEF) (prepared
from BALB/c mice) and NIH 3T3 (ATCC CRL-1658) cells were maintained in
Dulbecco’s modified Eagle’s medium (Invitrogen) supplemented with 10% fetal
calf serum (10% calf serum for NIH 3T3 cells) and 1% penicillin-streptomycin as
previously described (12). Bone marrow-derived macrophages (BMM) were ob-
tained from femur cells of male mice 10 to 12 weeks after gestation using
standard protocols; cells were maintained in Dulbecco’s modified Eagle’s
medium-F12, with 10% L929-conditioned medium, 10% fetal calf serum, and 1%
penicillin-streptomycin. Cells were either mock infected or infected with wild-
type virus (Smith strain) generated from the recombinant C3X bacterial artificial
chromosome clone described in reference 11. Virus was propagated in NIH 3T3
cells, and titers were determined by standard plaque assay on MEF.
Cloning and sequencing. Small RNAs were cloned following a protocol similar
to previously described protocols (24, 36). Briefly, BMM and MEF cells were
infected with virus at a multiplicity of infection (MOI) of 1.0. RNA was extracted
using TRIzol (Invitrogen) after 72 h, and 100 g was loaded onto a 15%
denaturing gel using radiolabeled RNA markers of 19 and 24 nt (CGUACGC
GGGUUUAAACCA and CGUACGCGGAAUAGUUUAAACUGU) that
contained PmeI restriction sites (36). The gel slice was eluted overnight in 0.1
mM EDTA and then ethanol precipitated. Purified RNA was ligated with T4
RNA ligase (New England Biolabs) to a 5 adapter (ATCGTaggcaccugaaa
[DNA shown in uppercase and RNA shown in lowercase]; Eurogentec) and a 5
adenylated 3 adapter available from Integrated DNA Technologies (rAppCTG
TAGGCACCATCAAddC, which is used for MEF cloning, and rAppTTTAAC
CGCGAATTCCAGddC, which is used for BMM cloning). Adapters were de-
signed to prevent self-ligation, and products were gel purified after each step.
Ligated RNA was reverse transcribed (ATTGATGGTGCCTAC) using Super-
script III reverse transcriptase (Invitrogen) and PCR amplified (forward primer,
ATCGTAGGCACCTGAAA; reverse primer, ATTGATGGTGCCTACAG).
PCR products were digested with PmeI (to eliminate size markers) and BanI,
followed by concatamerization with T4 DNA ligase (New England Biolabs).
Concatemers were incubated with Taq DNA polymerase to fill in the 3 ends and
were then cloned (TOPO TA cloning kit; Invitrogen) and sequenced (GATC
Biotech). The 392 sequenced clones from MEF and 212 clones from BMM were
blasted against the mouse and viral genomes, allowing for two gaps or mis-
matches. After validation, the raw sequence data were reexamined for the viral
clones to allow for additional mismatches (primarily additions of nongenomic
sequence at the 3 end, as reported below in Table 2).
Northern blot analysis. Northern blots were performed based on protocols
described elsewhere (26) (web.wi.mit.edu/bartel/pub). Briefly, RNA was ex-
tracted from NIH 3T3 cells that were mock infected or infected with MCMV at
a MOI of 2 after 72 h.
The integrity of the RNA was assessed according to the standards developed
with the 2100 Bioanalyzer (Agilent); all RNA samples used for analysis had an
RNA integrity number (RIN number) of 9.0, indicating high-quality RNA with
minimal degradation products. Twenty micrograms of RNA per lane was loaded
onto a 15% polyacrylamide gel, along with 32P-labeled Decade RNA markers
(Ambion) and then electroblotted onto a GeneScreen Plus membrane (Perkin-
Elmer). Membranes were hybridized overnight with 32P-labeled probes comple-
mentary to the mature miRNA. We also tested probes with locked nucleic acid
substitutions at every third position for mir-M23-1, mir-m59-1-5p, mir-m59-2,
and mir-m107-1-3p, which displayed a faint signal with the unmodified probes;
these probes were hybridized and washed under low-stringency conditions as
described elsewhere at 37 to 42°C (51). However, this did not significantly
improve detection, and results are shown below in Fig. 2 are with unmodified
probes, with the exception of mir-m59-2. Probes complementary to murine
mir-16 and murine 5S RNA (AAGCCTACAGCACCCGGTATTC) were used
as positive controls. Membranes were exposed to a PhosphorImager overnight,
scanned with a Typhoon scanner, and imaged using ImageQuant (Molecular
Dynamics); membranes were stripped and reused up to four times.
RT-PCR. RNA extracted for cloning studies (prior to size fractionation [see
above]) was used for the reverse transcription-PCR (RT-PCR) experiments in
Fig. 4 (infections were performed with NIH 3T3 cells, MEF, and BMM cells in
parallel). For kinetic class experiments, NIH 3T3 cells were incubated with
cycloheximide (Sigma) at 100 g/ml for 30 min prior to infection (MOI of 2) until
24 h postinfection (2). Experiments were also performed in the presence or
absence of phosphonoacetic acid (Sigma) at 250 g/ml for 24 h. RNA samples
were treated with DNase (Invitrogen) prior to reverse transcription (although
DNase treatment did not alter quantitative RT-PCR [qRT-PCR] results com-
pared to non-DNase-treated RNA [data not shown]). qRT-PCR was performed
using the Ncode SYBR green miRNA qRT-PCR kit (Invitrogen). Briefly, the
extracted total RNA was poly(A) tailed and then subjected to reverse transcrip-
tion with a poly(T) adapter primer. qRT-PCR was then performed using the
reverse qRT-PCR primer provided in the kit and a forward primer identical in
sequence to the mature miRNA of interest (exceptions are noted below). In this
protocol, the amplified product is roughly 65 nt long and includes the mature
miRNA sequence, a portion of the poly(A) tail, and the sequence incorporated
by the poly(T) adapter primer. Data were collected using the Mx3000P instru-
ment (Stratagene) and analyzed with the associated software. Conditions were
optimized so that only one dissociation product was observed with each primer.
This required using a temperature cycle of 50°C for 2 min, 95°C for 2 min,
followed by 45 cycles (with 1 cycle consisting of 15 s at 95°C, 15 s at 64°C and 20 s
at 72°C), as previously reported in detail (46). All miRNAs validated in this study
(listed below in Table 2) were analyzed by qRT-PCR except for the sequences
labeled with asterisks and mir-M95-1, mir-M23-2, and mir-m107-1-3p (probes
against the latter two yielded a signal in samples in which Dicer was knocked
down, which indicates that they are not specific for detection of the mature
miRNA and were therefore excluded from analysis; A. Buck, unpublished data).
All forward primers were identical to the miRNA sequences listed in Table 2
(unbracketed), with the following exceptions, which were shortened by 1 or 2 nt
at the 3 end: mir-m01-4, TCCTATGCTAACACGTGCGCG; mir-m22-1, TTC
CCCGTCCGTACCGAGGC; mir-M88-1, CAGAAGTCGATGTCGGGGT;
and mir-m108-2-3p, GTGACTCGAGACGAGTGACCG. Standard curves for
all miRNA primers demonstrated between 95 and 110% PCR efficiency as well
as homogeneous dissociation curves with the expected melting temperature (74
to 78°C) (46). A probe to detect murine 5S RNA was used for normalization of
qRT-PCR data; the probe was designed to be identical to the 3 end of murine
5S RNA (5-GAATACCGGGTGCTGTAGGCTT-3). RT-PCR products were
examined on 2.5% agarose gels as well as Lab901 D800 ScreenTape, which
automatically separated and sized the amplified products by gel electrophoresis
and integrated software.
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RESULTS
Computational prediction of MCMV miRNAs. On the basis
of the success of miRNA computational predictions in other
herpesviruses (36), we applied precursor feature classification
(using a machine learning approach) with support vector ma-
chines to classify the occurrence of precursor miRNAs in
MCMV. A total of 105,051 hairpin structures predicted by the
RNAfold program were classified by the SVM, and using a
lower bound of 0.1 for the SVM score, 6,840 hairpins were
subsequently processed by the RANDfold program. This pro-
gram reshuffles the sequence and predicts corresponding struc-
ture for each of the hairpins based on 500 simulations. On the
basis of permutation testing from the simulation runs, we as-
signed the reported P value to exceed 0.08 and obtained 2,155
hairpin structures (this cutoff has 95% sensitivity for known
human miRNAs). After removing overlapping predictions, 582
remained.
Of the 12 precursor miRNAs cloned in this study (Fig. 1), 9
were represented in these predictions, representing 75% sen-
sitivity. This method appears slightly more sensitive than an-
other prediction method reported recently (where 7 of the 12
precursors cloned here were represented in the 579 predic-
tions) (29). However, such a large number of predictions is not
highly useful if the vast majority are false positives and the
intent is to pursue target prediction or experimental validation.
We therefore examined the specificity of our predictions by
further ranking them according to the SVM score. The nine
cloned and predicted precursors ranked throughout the top
half of the list of 582 predicted hairpin structures (from num-
ber 3 to number 263); notably, 4 of the cloned precursors are
represented in the top 10 predictions (listed in Table 1), and an
FIG. 1. Secondary structures of MCMV precursor miRNAs. The predicted stem-loop structures from the mfold program are depicted with
cloned miRNAs indicated in brackets. Two mature miRNAs were cloned from the stem-loop precursors for mir-m01-4, mir-m01-3, mir-m01-2, and
mir-M23-2; the asterisk indicates the sequence that is less likely to be incorporated into the RNA-induced silencing complex. We depict only one
precursor for mir-m108-2-3p and mir-m108-2-5p.2, although the organization of these mature miRNAs within the precursor (5 overhangs) is not
characteristic of a typical intermediate.
TABLE 1. Locations of predicted precursor miRNAs on the
MCMV genome
SVM score P valuea Location (nt)b
0.99997 0.00399 90262–90366 ()
0.99996 0.00200 131297–131401 ()
0.99993 0.00798 556–660 ()
0.99991 0.00200 23446–23550 ()
0.99990 0.01198 174754–174858 ()
0.99989 0.00200 1985–2089 ()c
0.99988 0.00200 561–665 ()
0.99988 0.00200 57377–57481 ()c
0.99971 0.00200 23645–23749 ()
0.99970 0.00399 204375–204479 ()
a P values from RANDfold program.
b The location of the predicted precursor miRNA on the plus strand () or
minus strand () is indicated in parentheses. The precursors in bold type were
validated in this report.
c These precursors were validated in the accompanying report by Do¨lken
et al. (6a).
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additional 2 were validated in the accompanying report by
Do¨lken et al. (6a), giving a success rate of 6/10 for this cutoff.
This demonstrates that the SVM score (derived as described
above) is a useful criterion for scoring miRNAs; additional
analysis, such as deep sequencing, may shed light on how to
better refine the best cutoff for specificity. It is worth mention-
ing that in this list of 10 precursors, two of the predictions are
the reverse complements of one another (nt 556 to 660 on the
plus strand and nt 561 to 665 on the minus strand [Table 1]),
such that stem-loop structures are predicted on complemen-
tary strands of genome in specific locations. This is consistent
with our cloning results that demonstrate miRNAs are derived
from complementary strands of the genome in overlapping
regions (below).
Sequencing results of miRNAs cloned from infected cells.
Cloning of small RNAs has proven a successful method for
experimentally identifying miRNAs in a variety of viruses (36).
In two previous cloning studies with HCMV, either 1% or
18% of the total clones in each study possessed viral content,
potentially due to differences in the infection conditions or cell
lines (7, 36). Thus, in order to screen for an efficient experi-
mental design in our cloning studies, we initially sequenced a
set of clones (200 each) from both infected MEF and BMM
cells after 72 h. The ratio of viral to mouse RNA was assessed
by BLAST analysis and was substantially greater in the MEF
cells than in the BMM cells (30% viral clones compared to
0.5% viral clones, respectively). We therefore performed ad-
ditional sequencing with the infected MEF cells to isolate 123
viral clones (31% of the 392 total clones). From these clones,
a total of 24 unique small viral RNAs were identified, and 17
of these sequences were scored as miRNAs according to the
following criteria. (i) The sequence flanking the miRNAs is
predicted to fold into a stem-loop structure with the lowest free
energy. (ii) The cloned sequence is detected as a homogeneous
band of the appropriate size on a Northern blot (1). In four
cases, two of the cloned miRNAs originated from the same
precursor (noted in Table 2). We have used asterisks to indi-
cate the strand that is less likely to be incorporated into the
RNA-induced silencing complex, according to the higher sta-
bility of base pairing at the 5 end, although it appears likely
that both strands could function as miRNAs, since they are
readily detected by Northern blot analysis (Fig. 2A). Four
additional cloned RNAs were detected by Northern blotting
(listed in Table 2), but we did not classify these as miRNAs
based on their faint and heterogeneous detection (mir-m59-1-
5p, mir-m59-2, and mir-M87-1) or length (mir-m55-1, cloned
as 25 nt). However, we have named them to be consistent with
the accompanying report by Do¨lken et al. (6a), in which the
RNAs were scored as miRNAs (mir-m59-1-5p is in the 5 arm
of the depicted pre-miRNA for mir-m59-1 in that study). A
distinction between our two studies is that we utilized North-
ern blot detection as a criterion for scoring miRNAs. However,
TABLE 2. MCMV miRNAs isolated from MEFs
MCMV miRNAa Sequenceb No. ofclones
Genome
location (nt)c
mir-m01-4* CGCCGCGUGGUAGCAUUAGAACC 2 394–416 ()
mir-m01-4 UCCUAUGCUAACACGUGCGCGUGA 4 435–456 ()
mir-m01-3* GGAACGCUCGCUUCACGGCUCU 1 574–595 ()
mir-m01-3 GGUGAAGCGACUGUUGCCUCGAA 38 615–636 ()
mir-m01-2* CGUUCGACACGGUUUCCUUCGA 4 770–791 ()
mir-m01-2 GAAGAGAAUCGGGUUGGAACGGU 2 813–834 ()
mir-M23-2d AUGGGGGCCUCGGUCAAGCGG(UAC) 5 23468–23488 ()
CACGAUGGGGGCCUCGGUCAAG 1 23471–23492 ()
mir-M23-2* UGAACGUGUCCCCUAUCGGUGG 2 23509–23530 ()
mir-m21-1 AUAGGGGACACGUUCAAGCCG 1 23515–23535 ()
mir-M23-1 GGGCUCCUGCGUCGGCCCGAGGC(U)A 3 23668–23689 ()
mir-m22-1 UUCCCCGUCCGUACCGAGGCCA(AU) 2 23707–23728 ()
mir-M88-1 CAGAAGUCGAUGUCGGGGUCU 5 131357–131377 ()
mir-M95-1 GGUCGUGGGCUUGUGUCGCUUG(A) 3 138206–138226 ()
mir-m108-2-3p GUGACUCGAGACGAGUGACCGGUC(A) 24 162073–162095 ()
mir-m108-2-5p.2 UCACUCGUCGCGAGCGGUCAC(C) 4 162125–162145 ()
mir-m107-1-3p UGCUCGCGUCGAGUGACCGCUC 1 162113–162134 ()
mir-m108-1e UUUCUGACGGUGGCUCGUGUCG 2 162364–162385 ()
mir-m55-1f UGGUGAUCGGCGUGCUAGCCGUCGU 3 83412–83436 ()
mir-m59-1(5p)d,f CGCUGUCGGCCGAGGCACUGC 1 94485–94505 ()
GCUGUCGGCCGAGGCACUGCU 3 94486–94506 ()
UGUCGGCCGAGGCACTGCUCCU 1 94488–94509 ()
mir-m59-2f CCGAAGAGCCCUCACAGAGCC 4 94970–94990 ()
mir-M87-1f AGGCAGCCGUCGGCAGCGGCAG(AGA) 2 128875–128896 ()
a The MCMV miRNA names listed in bold type are miRNAs whose precursors were predicted by computational analysis. An asterisk at the end of the miRNA name
indicates that it is less likely to be incorporated into the RNA-induced silencing complex.
b The nucleotides noted in brackets represent additional nucleotides that were sequenced in a minority of the clones. Nucleotides in parentheses are not consistent
with the genomic sequence (if they were cloned multiple times, the most common nucleotide is listed).
c The location of the predicted precursor miRNA on the plus strand () or minus strand () is indicated in parentheses.
d The cloned sequence variations of the RNAs are listed to depict the 5 heterogeneity; mir-m59-1 is listed as “5p,” since the other arm of the precursor was cloned
by Do¨lken et al. (6a).
e The nucleotides underlined in the mir-m108-1 sequence are listed as adenosines in GenBank (NC_004065); sequencing of our recombinant virus, as well as the
Smith strain virus from the ATCC, revealed that the nucleotides in the genomic sequence at these positions are guanosines (data not shown).
f These were not scored as miRNAs in this report but are named according to the accompanying report by Do¨lken et al. (6a).
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some of the heterogeneity we observe by Northern blotting
could be related to posttranscriptional modification of the
miRNAs (S. Pfeffer, personal communication).
From the 17 mature miRNAs cloned and validated, 6 (de-
rived from 4 distinct precursors) are represented in the top 10
predicted precursors in Table 1 (these are noted in bold type in
Tables 1 and 2). Notably, two miRNAs were highly abundant
in these cloning studies: mir-m01-3 represented 30% of viral
clones and was present in the top 10 predicted precursors, and
mir-m108-2-3p represented 20% of viral clones. On the basis
of data sharing with S. Pfeffer (IBMP-CNRS) and discussion
with S. Griffiths-Jones (University of Manchester), we agreed
on a naming convention to reflect the genomic locations of the
miRNAs and to facilitate comparison and standardization of
our results. These names are as they will appear in the miRNA
registry (15).
There are a few notable properties of the cloned miRNAs.
Several sequences exhibited 3 heterogeneity, as has been seen
with many miRNAs previously (24, 36, 52), as well as non-
genomic sequence at the 3 end (23) (Table 2). mir-M23-2 is
the only validated miRNA that exhibited significant 5 hetero-
geneity; mir-M23-2 was cloned with two different 5 start sites.
Although this result could be indicative of a random degrada-
tion product, we include this as a validated miRNA because it
is detected as an abundant, homogeneous product on a North-
ern blot (Fig. 2A) and is expected to originate from a precursor
stem-loop structure, since mir-M23-2* was also cloned (and it
is predicted in Table 1).
FIG. 2. Northern blots of MCMV miRNAs. RNA was extracted from NIH 3T3 cells 72 h after viral infection (V). RNA from mock-infected
cells (M) is included for comparison. Twenty micrograms of RNA was loaded onto each lane, and an RNA marker was included for size reference
(the unlabeled, leftmost lane of each blot). Probes directed against mouse mir16 and 5S RNA were used as controls. The positions of molecular
size markers (in nucleotides) are shown to the left of the blots. Mus musculus (mmu) mir-16 was also included in the analysis. (A) Blots of miRNAs
validated in this report; (B) blots of RNAs cloned but not scored as miRNAs in this report.
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Structure and organization of the microRNAs. There are a
number of notable structural features of the cloned miRNAs.
In particular, the miRNAs are organized into five genomic
regions and three clusters (Fig. 3A). In the clusters defined in
this study, miRNAs occur within 500 nt of one another, on
either strand of the genome. We name clusters in this study
according to the open reading frames (ORFs) in the proximity
of the miRNAs. In the clusters around m21/m22/M23 and
m107/m108, miRNAs exist in overlapping regions on comple-
mentary strands of the genome, which has not previously been
observed with other viral miRNAs. According to the gene
annotation system of Rawlinson and colleagues (41) (system
adopted for Fig. 3A), 9 of the 17 miRNAs fall outside of the
annotated regions (in predicted 3 untranslated regions [3UTRs] or
5 to predicted ORFs), and 8 fall within annotated ORFs. Five
miRNAs also lie opposite predicted ORFs. Within the cluster
FIG. 3. Genomic organization of MCMV miRNAs. (A) Diagram depicting the regions of the MCMV genome that contain MCMV miRNAs.
Rulers indicate the genomic position in kilobases; broken lines are used to indicate a break in the scale. The predicted open reading frames in the
vicinity of the miRNAs are noted with open triangles and are above the genome line if they are on the sense strand and below the genome line
if they are on the antisense strand (the same format is used for depicting the miRNAs). The black rectangles are the predicted miRNA precursors
from Table 1, overlaid on the miRNAs cloned in this study. The oval inset depicts the spatial relationship (not to scale) between mir-m108-2-3p,
mir-m108-2-5p.2, and mir-m108-1 (drawn as black triangles) and the two introns previously identified (depicted from 3 to 5, to be consistent with
the diagram of the whole genome above); both the 5 splice sites are noted as well as the 3 splice site. (B) Northern blot of mir-m108-2-3p at the
indicated time points (hours) after infection. Lanes: M, mock-infected cells; V, virus-infected cells. The positions of molecular size markers (in
nucleotides) are shown to the left of the blot. The asterisk indicates the faint precursor band near the 50-nt RNA marker.
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near m01, two precursor miRNAs are within the ORF, while
one precursor miRNA lies in the 3UTR (Fig. 3A). Previous
RT-PCR analysis detected m01 in NIH 3T3 cells using RT-
PCR (50); however, the exact boundaries of the predicted
ORF have not been experimentally verified. On the basis of the
location of miRNAs near m22 and M23 (within or between
ORFs), it is not obvious from which transcripts these miRNAs
might be derived.
Of particular interest are three miRNAs, mir-m108-2-3p,
mir-m108-2-5p.2, and mir-m108-1 that lie within and 3 to
m108 (41). A recent report by Kulesza and Shenk (21) dem-
onstrated that MCMV encodes a 7.2-kb stable intron that
occurs in this vicinity; a less abundant 8.0-kb intron was also
reported (21), which would encompass the miRNAs in this
cluster (Fig. 3A, inset). It is expected that these miRNAs could
exist as either introns or exons, depending on splicing. The
second most abundant miRNA (20% of viral clones), mir-
m108-2-3p, is contained in this region, and the processed (23-
nt) miRNA is readily abundant on a Northern blot and displays
a clear band consistent with a precursor sequence (Fig. 2A and
3B). Work is currently under way to determine the relationship
between the miRNAs in this cluster and the 7.2-kb and 8.0-kb
introns.
According to the stem-loop precursor sequences predicted
for the MCMV miRNAs, the length of the 3 overhangs be-
tween mature miRNAs ranges from 1 to 5 nt; these overhang
lengths have also been seen previously with miRNAs from
Kaposi’s sarcoma-associated herpesvirus (36), HCMV (7) and
Marek’s disease virus (MDV) (52). Curiously, both mir-m108-
2-3p and mir-m108-2-5p.2 could be derived from the same
precursor but do not appear to originate from a classical in-
termediate, since they would require 5 overhangs (rather than
3 overhangs). We questioned whether this result might indi-
cate that these RNAs are small interfering RNAs (siRNAs),
rather than miRNAs (1), which would be consistent with
RNAs being cloned from both strands of the genome in over-
lapping regions (Table 2). siRNAs come from long double-
stranded RNA (dsRNA) molecules processed such that many
small RNAs accumulate from both strands of the dsRNA; if
this were the case, therefore, mir-m108-2-3p and mir-m108-2-
5p.2 would be processed as siRNAs from a fully complemen-
tary dsRNA intermediate. This would require that both the
antisense strand and the sense strand be transcribed. In sup-
port of this, we did detect a miRNA, mir-m107-1, on the sense
strand that overlaps mir-m108-2-5p.2 (Fig. 3A). However, both
mir-m108-2-3p and mir-m107-1 have distinct precursors that
are detected on Northern blots (Fig. 2A), and a probe directed
against the sequence between mir-m108-2-3p and mir-m108-
2-5p.2 failed to detect any small RNAs on a Northern blot or
by RT-PCR (data not shown). Also relevant is the fact that
Do¨lken et al. (6a) cloned a different 5 version of mir-m108-2,
which forms a more classical miRNA intermediate with mir-
m108-2-3p.
Detection in macrophage cells. Since macrophages are as-
sumed to be a key cell type for in vivo infection, we performed
RT-PCR to determine whether these MCMV miRNAs are
expressed in both fibroblasts and macrophage cells. Although
initial cloning studies with BMM cells showed a low level of
viral content (see above), all of the validated MCMV miRNAs
in Table 2 were readily detected in macrophage (BMM) and
fibroblast (NIH 3T3) cells using RT-PCR, with the exception
of miR-m108-1. The RT-PCR products were sized at the pre-
dicted length (65 to 70 nt), based on detection of the mature
miRNA with the poly(A) tail protocol described above. Gel
analysis confirms that the products are specific to infected cells
(Fig. 4).
Kinetic class analysis of MCMV miRNAs. Like other her-
pesviruses, the expression of genes in MCMV is organized into
a cascade of immediate-early, early, and late transcription (32).
The immediate-early genes are the first genes expressed upon
infection and are strictly dependent on the host cell transla-
tional machinery. These genes are implicated in the evasion of
host immune responses and the control of early and late tran-
scripts of the virus. Early genes are, by definition, dependent
on the immediate-early genes, while late genes are dependent
on viral DNA replication. In order to determine the kinetic
classes of each miRNA, viral infections were performed in the
presence of cycloheximide (a block to immediate-early protein
synthesis) or phosphonoacetic acid (an inhibitor of viral repli-
cation), and the relative amount of each miRNA was quanti-
fied. Quantification of miRNAs was performed using SYBR
green RT-PCR which was optimized to ensure the specificity of
detection for the mature miRNAs (Materials and Methods).
FIG. 4. Detection of MCMV miRNAs in bone marrow-derived
macrophages. RNA was extracted from NIH 3T3 (3T3) or BMM cells
72 h after infection with MCMV (MOI of 1). RNA from mock-infected
cells (M) and virus-infected (V) cells was poly(A) tailed, reverse
transcribed, and subjected to RT-PCR. The RT-PCR product (0.5 l)
was loaded on the Lab901 D800 ScreenTape, which automatically
separated and sized the amplified products by gel electrophoresis and
integrated software. The bands indicated with an asterisk were all sized
between 64 and 70 nt, as expected from the RT-PCR protocol; addi-
tional bands (band with two asterisks) were observed for mir-m108-
2-3p that corresponded to primer-dimer products with distinguishable
dissociation curves.
VOL. 81, 2007 microRNA CLUSTERS IN MCMV 13767
As shown in Fig. 5A, all MCMV miRNAs examined are sen-
sitive to cycloheximide treatment and therefore require imme-
diate-early proteins for their expression. mir-m108-2-3p, mir-
m108-2-5p.2, and mir-m108-1 also show dependence on viral
replication and, therefore, fall into the late kinetic class. The
Northern blots in Fig. 5B demonstrate that mir-M23-2 is an
early gene product and mir-m107-1-3p is a late gene product
(these miRNAs were unsuitable for qRT-PCR analysis; Mate-
rials and Methods); however, based on the low signal observed
for mir-m107-1-3p, it is difficult to accurately characterize this
miRNA. Northern blots of mir-m01-2 and mir-m108-2-3p are
provided (Fig. 5B) to compare and validate the qRT-PCR data
in Fig. 5A. We also examined murine mir16 as a control under
these conditions to ensure that the drugs used did not interfere
with the biogenesis of the mature miRNAs (Fig. 5A). How-
ever, one assumption in using this control is that host and viral
miRNAs utilize the same (host) protein factors for their bio-
genesis, which requires further characterization. Unlike other
viral kinetic class analyses, we identified the presence of the
mature miRNA product with qRT-PCR, not the transcript
from which it is derived. It is possible, therefore, that the
miRNA transcripts are produced in an earlier class but require
other viral products for their biogenesis.
DISCUSSION
Since the discovery of miRNAs in EBV 3 years ago, research
with viral miRNAs has greatly enhanced our knowledge of
miRNA biogenesis and virus-host interactions (6, 44, 45). In
the current study, we utilized a bioinformatic approach to
examine the potential for precursor miRNA sequences in the
MCMV genome. Although this study was not exhaustive, 6 of
the cloned mature miRNAs (derived from 4 precursors) are
contained within the top 10 predicted precursors; the accom-
panying report by Do¨lken et al. (6a) further validates 2 of the
predicted precursors, as noted in Table 1. In summary, we have
identified a total of 17 mature miRNAs from MCMV, adding
to the list of roughly 100 known miRNAs from herpesviruses
(15). In addition, we identified a highly abundant miRNA,
mir-m108-2-3p (20% of viral clones) from a region of the
genome that was not predicted to encode precursors in our
computational analysis. The location of this miRNA, and the
other miRNAs that cluster in this region, is particularly rele-
vant because they are in the immediate vicinity of a previously
identified stable intron and can in exist in two different forms,
depending on splicing. Significantly, Shenk and colleagues
showed that mutation of the splice sites for the 7.2-kb intron
influences the progression from the acute phase to the persis-
tent phase of infection in vivo; this mutation could also influ-
ence the form (exonic or intronic) in which mir-m108-2-3p,
mir-m108-2-5p.2, and mir-m108-1 exist (Fig. 3A). Understand-
ing the relationship between this phenotype and the regulation
of the miRNAs is an important topic that requires further
study. It is noteworthy that work with HSV demonstrated that
a miRNA (mir-LAT1) is also positioned adjacent to a stable
intron in the latency-associated transcript (LAT). It remains to
be seen whether the spatial relationship between miRNAs and
stable introns is a common feature in viruses and what role this
plays in pathogenesis. However, the MCMV stable intron is
orthologous to the HCMV stable intron (20, 39), and miRNAs
have not previously been cloned in its vicinity.
In general, the lack of conservation between MCMV and
HCMV miRNAs is consistent with the general lack of conser-
vation among herpesvirus-encoded miRNAs (33, 36). One re-
cent report demonstrated conservation of 7 out of 16 miRNAs
in EBV and rhesus lymphocryptovirus (separated by 13 mil-
lion years) (5); however, analysis of miRNAs in Marek’s dis-
ease virus type 1 (MDV-1) and MDV-2 (estimated to be sep-
FIG. 5. Kinetic classes of MCMV miRNAs. (A) Relative values of
each miRNA from RNA samples extracted from NIH 3T3 cells in-
fected with MCMV (MOI of 2) in the presence or absence of cyclo-
heximide (CHX) (100 g/ml) or phosphonoacetic acid (PAA) (250
g/ml) after 24 h. The RNA was from mock-infected cells (M) or
virus-infected cells (V). Data shown are the averages for two biolog-
ical replicates (each of which was an average from three technical
replicates); error bars represent the standard deviations. Data were
normalized for each miRNA by setting the quantity of the miRNA in
untreated, but infected, samples at 1.0. Mus musculus (mmu) mir-16
was also included in the analysis. (B) Northern blots of mir-m01-2 and
mir-m108-2-3p (for validation of the qRT-PCR results) are shown on
the left. Blots of mir-M23-2 and mir-m107-1-3p shown on the right are
included for kinetic class characterization of these miRNAs. The positions
of molecular size markers (in nucleotides) are shown to the left of the
blots.
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arated by 26 million years) showed no sequence conservation
(52). Although this lack of conservation could indicate a lack of
functional significance, it also possible that a primary function
of virus-encoded miRNAs is to target host genes, as has been
demonstrated in HSV-1 and HCMV (cited above). The host
3UTR target sites need not be conserved to be functionally
relevant (8), and the viral miRNA sequences could be signif-
icantly influenced by coevolution with the host. This is partic-
ularly relevant in the case of herpesviruses, whose evolution
has occurred on the same timescale as mammalian speciation
(31). Ultimately, true understanding of herpesvirus miRNA
function and evolution will require a global analysis of their
targets, both host and viral. Potential host (mouse) targets of
these MCMV miRNAs were examined using the miRANDA
program (A. Enright, personal communication); however, each
miRNA is predicted to target up to 800 genes, and experi-
mental validation is required to understand the relevance of
these predictions.
A striking feature of the MCMV miRNAs is their localiza-
tion on both strands of the genome in specific regions. In the
cluster around m107/m108, for example, mir-m107-1-3p (on
the sense strand) overlaps mir-m108-2-5p.2 on the antisense
strand. Previously it was shown in SV40 that a miRNA targets
a perfectly complementary mRNA that was encoded on the
opposite strand of the genome. However, mir-m107-1-3p over-
laps mir-m108-2-5p.2 by only 10 bp, and there is no precedence
for miRNAs regulating one another in this fashion. The de-
tection of distinct pre-miRNAs for mir-m108-2-3p and mir-
m107-1-3p (Fig. 2 and Fig. 5B) argues against the possibility
that they are siRNAs derived from a dsRNA intermediate.
According to computational predictions, precursor miRNAs
are predicted to occur on complementary strands of the ge-
nome in overlapping regions (Table 1). It may be that this is
another way in which viruses have evolved to most efficiently
utilize their genomes. Alternatively, there may be some evolu-
tionary or regulatory factors that select for such a genomic
organization.
An important result from this study is the identification of
viral miRNAs clustered in close proximity (	500 nt) and on
complementary strands of the genome within and around pre-
dicted ORFs. For example, miRNAs are clustered around m1
and m22, which have not been shown to encode proteins.
These results imply that there are likely to be noncoding gene
transcripts which are not accounted for in the current genomic
maps based on annotation of ORFs and that the boundaries of
the predicted ORFs at present do not accurately reflect the
location of miRNA transcriptional activity. Relevant to this, a
recent cDNA cloning study from HCMV-infected cells dem-
onstrated that 45% of the clones were from regions of the
genome that were predicted to be noncoding (53).
It is now widely recognized that CMV is not only capable of
evading the immune response but it can also proactively induce
immunosuppression in humans (34). Understanding the mech-
anisms by which CMV establishes an acute infection and
persists in a latent state is, therefore, of clinical relevance.
Although extensive work has been undertaken in the charac-
terization of CMV open reading frames which are important
for viral function and immune evasion, there is still a lack of
understanding in the area of CMV-host interactions, which
evades the development of effective therapeutics (9). A recent
report with HCMV demonstrated that a 2.7-kb ncRNA inter-
acts with components of the mitochondrial respiratory chain
complex and thereby modulates cellular metabolic activity in
order to enable a productive viral life cycle (42). Clearly, there
are numerous potential mechanisms by which noncoding
RNAs, including miRNAs, could influence viral infection and
latency.
To conclude, we demonstrate by computational and cloning
analyses that MCMV has the capacity to encode miRNAs
clustered throughout the genome on complementary strands,
including in the vicinity of the 7.2-kb stable intron. This work
points to a variety of potential regulatory mechanisms for
MCMV miRNAs, the study of which will undoubtedly expand
the repertoire of virus-host interactions important for CMV
infection and latency.
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